Many patients with schizophrenia are poorly adherent with antipsychotic medications. The
newer, atypical antipsychotics may be more acceptable to patients and result in increased …

The successful management of schizophrenia is an enormous public health issue. Although
antipsychotic medications can be very helpful in reducing rates of relapse and …

Advances in psychopharmacology have produced medications with substantial efficacy in
the treatment of positive and negative symptoms of schizophrenia and the prevention of …

Background: Similar to patients with other chronic disorders, patients with serious mental
illness (SMI) are often poorly adherent with prescribed medications. Objective: We …

Objective Previous research has shown that a better therapeutic relationship (TR) predicts
more positive attitudes towards antipsychotic medication, but did not address whether it is …

BACKGROUND: Many patients recovering from a first psychotic episode will discontinue
medication against medical advice, even before a 1-year treatment course is completed …

Poor adherence to medication leads to symptom exacerbation and interferes with the
recovery process for patients with schizophrenia. Following baseline assessment, 142 …

Objective: To evaluate the efficacy of compliance therapy when delivered to outpatients with
schizophrenia or schizoaffective disorder. Method: Thirty patients with schizophrenia or …

Taking antipsychotic medication as prescribed is one of the best means patients have of
managing psychotic symptoms and preventing relapse. Yet, for various reasons, patients …

Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …